•  
  •  
  •  
  •  

2026-08-13 21:49:33

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT

Keywords Selected:  RossariBiotech

Stock Report

  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million
  • Rossari Biotech Ltd consolidated Q4 FY2026 PAT climbs to Rs. 45.96 crores
  • Rossari Biotech Ltd recommends final dividend of Rs. 0.50
  • Unitop Chemicals Pvt Ltd commissions 15000 MTPA ethoxylation capacity
  • Rossari Biotech Ltd Q3FY26 consolidated profit at Rs. 32.77 crores
  • Rossari Biotech Ltd Q2 FY2025-26 consolidated PAT increases to Rs. 36.87 crores
  • Rossari Biotech Ltd posts consolidated PAT of Rs. 33.59 crores in Q1 FY26
  • Rossari Biotech Limited recommends final dividend of Rs. 0.50
  • Rossari Biotech Ltd Q4FY25 consolidated profit up at Rs. 34.44 crores
  • Rossari Biotech Limited subsidiaries announce capacity expansion
  • Rossari Biotech Ltd reports consolidated PAT of Rs. 31.70 crores in Q3 FY2025
  • Rossari Biotech Ltd Q2 FY2025 consolidated profit up at Rs. 35.33 crores
  • Rossari Biotech Ltd consolidated Q1 FY2024-25 net profit rises to Rs. 34.89 crores
  • Rossari Biotech Ltd recommends final dividend of Rs. 0.50
  • Rossari Biotech Ltd Q4 FY2024 consolidated net profit at Rs. 34.13 crores
  • Rossari Biotech Ltd Q3 FY2024 consolidated PAT increases to Rs. 34.39 crores
  • Rossari Biotech Limited subsidiary to expand Ethoxylation Capacity
  • Rossari Biotech Ltd Q1FY24 consolidated PAT up at Rs. 29.21 crores
  • Rossari Biotech Limited recommends final dividend of Rs. 0.50
  • Rossari Biotech Ltd posts rise in consolidated PAT to Rs. 28.97 crores in Q4FY23
  • Rossari Biotech Ltd posts consolidated net profit of Rs. 25.68 crores in Q3FY23
  • Rossari Biotech Ltd Q2FY23 consolidated net profit falls to Rs. 23.91 crores
  • Rossari Biotech Ltd consolidated Q1FY23 profit climbs to Rs. 28.68 crores
  • Rossari Biotech Limited recommends final dividend of Rs. 0.50

Latest Post

  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025